Pictet Asset Management Holding SA Trims Position in Corteva, Inc. $CTVA

Pictet Asset Management Holding SA reduced its position in Corteva, Inc. (NYSE:CTVA) by 13.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 460,953 shares of the company’s stock after selling 74,421 shares during the period. Pictet Asset Management Holding SA’s holdings in Corteva were worth $38,583,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of CTVA. Brighton Jones LLC lifted its stake in shares of Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the period. Woodline Partners LP grew its position in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after purchasing an additional 16,644 shares during the period. EverSource Wealth Advisors LLC increased its stake in Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after purchasing an additional 980 shares during the last quarter. Cresset Asset Management LLC lifted its position in Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after buying an additional 181 shares during the period. Finally, Jump Financial LLC acquired a new stake in Corteva in the 2nd quarter worth about $1,464,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.

Corteva Stock Performance

NYSE CTVA opened at $84.66 on Wednesday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $85.63. The firm has a market capitalization of $56.62 billion, a P/E ratio of 49.80, a P/E/G ratio of 2.55 and a beta of 0.57. The business’s 50-day simple moving average is $79.51 and its 200-day simple moving average is $76.54.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm had revenue of $4.91 billion during the quarter, compared to the consensus estimate of $4.64 billion. During the same quarter in the prior year, the company earned $1.13 EPS. The company’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were given a $0.18 dividend. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio is presently 42.35%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of research analyst reports. Jefferies Financial Group upped their price objective on shares of Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. UBS Group lowered their target price on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating for the company in a report on Tuesday, June 9th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Corteva from $90.00 to $100.00 in a research report on Monday, May 11th. The Goldman Sachs Group increased their price target on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, April 14th. Finally, Berenberg Bank lifted their price target on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a report on Thursday, March 26th. Fourteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $88.81.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.